Skip to main content

Advertisement

Table 5 Duration of recombinant human follicle-stimulating hormone (r-hFSH) stimulation and total and daily r-hFSH doses required - Per-protocol population (patients who received hCG injections)

From: Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction

  CLD group LD group Total p
(n = 84) (n = 82) (N = 166)
Duration of stimulation, days 13.4 +/− 6.04 13.0 +/− 5.81 13.2 +/− 5.91 0.66
Daily dose, IU 78.5 +/− 8.95 85.5 +/− 15.88 81.9 +/− 13.28 <0.001
Total dose, IU 1092.9 +/− 665.19 1183.1 +/− 762.52 1137.4 +/− 714.18 0.42
  1. Data are mean +/− standard deviation.
  2. p values show the difference between treatment groups using analysis of variance.
  3. Values in bold are significant.
  4. CLD = chronic low-dose; hCG = human chorionic gonadotrophin; LD = low-dose.